SSRIs and Ejaculation: A Double-Blind, Randomized, Fixed-Dose Study With Paroxetine and Citalopram

@article{Waldinger2001SSRIsAE,
  title={SSRIs and Ejaculation: A Double-Blind, Randomized, Fixed-Dose Study With Paroxetine and Citalopram},
  author={Marcel D. Waldinger and Aeilko H. Zwinderman and Berend Olivier},
  journal={Journal of Clinical Psychopharmacology},
  year={2001},
  volume={21},
  pages={556-560}
}
Selective serotonin reuptake inhibitors (SSRIs) are known to induce delayed orgasm and ejaculation. However, different SSRIs may differentially delay ejaculation. A double-blind, fixed-dose study in healthy men with lifelong rapid ejaculation was performed to evaluate potential differences between clinically relevant doses of two selective serotonin reuptake inhibitors, paroxetine and citalopram, in their effects on ejaculation. Thirty men with an intravaginal ejaculation latency time (IELT… Expand
View on Wolters Kluwer
ncbi.nlm.nih.gov
100 Citations
Highly Influential Citations
1
Background Citations
16
Results Citations
4

100 Citations

Citation Type

Citation Type

Antidepressants and Ejaculation: A Double-Blind, Randomized, Fixed-Dose Study With Mirtazapine and Paroxetine
TLDR
Earlier findings that paroxetine, but not mirtazapine, significantly delays orgasm and ejaculation in men with early ejaculation are confirmed, whereas mirtzapine is devoid of any effect on it are confirmed. Expand
Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study
TLDR
It is indicated that citalopram has significantly better results in terms of IVELT and intercourse satisfaction versus placebo and to prolong the efficacy of this drug in PE. Expand
On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment.
TLDR
On-demand treatment with 25 mg clomipramine led to a clinical relevant ejaculation delay in men with lifelong premature ejaculation with an IELT of less than 1 minute, and in contrast, 20 mg paroxetine had no clinical relevant genitalia delay. Expand
Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study
TLDR
Treatment of patients with definite PE with a daily dose of escitalopram 10 mg/day resulted in a delay in ejaculation measured by IELT, and side effects of the drug that arose during therapy decreased gradually to become insignificant at 4 weeks of treatment. Expand
Safety and Efficacy of Tramadol in the Treatment of Premature Ejaculation: A Double-blind, Placebo-Controlled, Fixed-Dose, Randomized Study
Purpose: To evaluate the efficacy and safety of a new serotonergic centrally acting drug tramadol in delaying ejaculation in patients with premature ejaculation. Materials and Methods: Sixty-four… Expand
Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
TLDR
Oral escitalopram is an effective treatment for PE with long-term benefit for the patient after it is withdrawn, and further studies are required to draw final conclusions on the efficacy of this drug in PE. Expand
Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
TLDR
The results of the study show that tadalafil can increase the mean IELT and can be used for treatment of premature ejaculation in combination with paroxetine. Expand
The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study.
TLDR
Citalopram and fluoxetine did not directly affect penile erection as objectively assessed by RigiScan, although an impairment in the subjective assessment of erectile function was observed, and it was thought to be a possible consequence of the delayed ejaculation perceived as a trouble. Expand
On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions.
TLDR
On-demand SSRIs with short half-life that insufficiently delay ejaculation in men with IELTs less than 1 minute should be called ejaculation-delaying drugs rather than drugs against premature ejaculation. Expand
Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
TLDR
Dapoxetine treatment significantly prolonged IELT and improved PEP measures and was generally well tolerated in men with PE in the Asia-Pacific region. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Antidepressants and Ejaculation: A Double-Blind, Randomized, Placebo-Controlled, Fixed-Dose Study With Paroxetine, Sertraline, and Nefazodone
TLDR
A double-blind, placebo-controlled study in men with lifelong rapid ejaculation was performed to assess the effects of two selective serotonin (5-HT) reuptake inhibitors—paroxetine and sertraline—and the nefazodone on the latency to ejaculate. Expand
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
TLDR
In men with lifelong rapid ejaculation, paroxetine delayed ejaculation most strongly, whereas fluvoxamine delayed ejaculations the least, which suggests that ejaculation-delaying side effects of some SSRIs investigated in men with generalized rapid ejaculations may be extrapolated to men with less-rapid ejaculation. Expand
Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study.
TLDR
The daily use of 20 mg paroxetine may be considered as an adequate treatment for primary premature ejaculation and increasing the dose may lead to a further increase in ejaculation latency. Expand
Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study.
TLDR
Patients treated with paroxetine had significantly greater clinical improvement than the patients given placebo. Expand
Selective serotonin reuptake inhibitor‐induced sexual dysfunction: clinical and research considerations
TLDR
The ejaculation delaying effects of the SSRIs have been investigated in a double-blind, placebo-controlled study in men with rapid ejaculation, with fluvoxamine having by far the least disturbing effect on ejaculation. Expand
Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system
TLDR
The neurophysiology and the peripheral neuroanatomy of ejaculation is described and a review of the involvement of serotonin in the central nervous system in relation to serotonergic nuclei and their projections is provided. Expand
An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation.
TLDR
The results suggest that premature ejaculation could be operationally defined as an IELT < 1 min in more than 90% of episodes of sexual intercourse, independent of age and duration of relationship. Expand
Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour
TLDR
Investigations are ongoing to determine whether this differential mechanism of action also applies to the other SSRIs and whether there are differences between theSSRIs with respect to their effect on sexual behaviour in rodents. Expand
Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates.
TLDR
Fenfluramine's effects were blocked by the 5-HT2 antagonists, ritanserin and metergoline, while m-CPP's effectswere not blocked byThe peripheral 5- HT antagonist, xylamidine, indicating that tumescence can be elicited by serotonergic agents which act at non-5-HT1A sites in the central nervous system. Expand
Preclinical evidence on the psychotropic profile of fluvoxamine.
TLDR
Results of studies of the mechanism of action of fluvoxamine in which drug discrimination tests were performed with rats and pigeons suggest that the flu voxamine stimulus is not (or is only to a very limited degree) dependent on activation of 5-HT1A receptors or 5- HT1B/1D receptors, or both. Expand
...
1
2
3
...